natgillin/translations-raw huggingface dataset:
DJANG Tcheul Hy has been involved together with her husband KIM Yong Nam, her son KIM Su Gwang and her daughter-in-law KIM Kyong Hui in a pattern of deceptive financial practices which could contribute to the DPRK's nuclear-related, ballistic-missile-related or other weapons of mass destruction-related programmes.
Sodelovala je tudi pri več bančnih transferjih z računov svoje snahe KIM Kyong Hui na bančne račune zunaj Unije.
She was the owner of several bank accounts in the Union which were opened by her son KIM Su Gwang in her name.
Datum rojstva: 18.8.1976
She was also involved in several bank transfers from accounts from her daughter-in-law KIM Kyong Hui to bank accounts outside the Union.
Skupina strokovnjakov je ugotovila, da je KIM Suj Gwang agent urada Reconnaissance General Bureau, tj. subjekta, ki je na seznamu Združenih narodov.
DOB: 18.8.1976
Ugotovila je tudi, da KIM Su Gwang in njegov oče KIM Yong Nam sodelujeta v vzorcu goljufivih finančnih praks, ki bi lahko prispeval k programom DLRK, povezanim z jedrskim orožjem, balističnimi izstrelki ali drugim orožjem za množično uničevanje.
KIM Su Gwang has been identified by the Panel of Experts as an agent of the Reconnaissance General Bureau, an entity which has been designated by the United Nations.
KIM Su Gwang je odprl več bančnih računov v več državah članicah, tudi na imena družinskih članov.
He and his father KIM Yong Nam have been identified by the Panel of Experts as engaging in a pattern of deceptive financial practices which could contribute to the DPRK's nuclear-related, ballistic-missile-related or other weapons of mass destruction-related programmes.
Ko je delal kot diplomat, je sodeloval je pri različnih večjih bančnih transferjih na bančne račune v Uniji oziroma na račune zunaj Unije, tudi na račune, odprte na ime soproge KIM Kyong Hui.“
KIM Su Gwang has opened multiple bank accounts in several Member States, including under family members' names.
vnosi se preštevilčijo 1–6.
He has been involved in various large bank transfers to bank accounts in the Union or to accounts outside the Union while working as a diplomat, including to accounts in the name of his spouse KIM Kyong Hui.’
V Prilogi XVI k Uredbi (EU) 2017/1509 se pod naslovom „Seznam oseb, subjektov ali organov iz člena 34(1) in (3)“ in podnaslovom „(a) Fizične osebe“ naslednji vnosi nadomestijo:
the entries are renumbered 1-6.
tudi: JON Chol Yong
In Annex XVI to Regulation (EU) 2017/1509, under the heading ‘List of persons, entities or bodies referred to in Article 34(1) and 34(3)’, subheading ‘(a) Natural persons’, the following entry is replaced as follows:
Št. potnega lista: 563410192
a.k.a: JON Chol Yong
Datum rojstva: 30.4.1975
Passport number: 563410192
Predstavnik družbe Green Pine Associated Corporation in diplomat DLRK v Angoli.
Diplomat DPRK Embassy, Angola
Green Pine je na seznamu ZN zaradi svojih dejavnosti, vključno s kršitvijo embarga ZN na orožje.
Date of birth: 30.4.1975
Družba Green Pine se je tudi pogajala o pogodbah za prenovo plovil angolske mornarice, ki kršijo prepovedi, uvedene z resolucijami Varnostnega sveta Združenih narodov.“
Commission Implementing Regulation (EU) 2018/1075
Izvedbena uredba Komisije (EU) 2018/1075
renewing the approval of the active substance Ampelomyces quisqualis strain AQ10, as a low-risk active substance, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011
o obnovitvi odobritve aktivne snovi Ampelomyces quisqualis, sev AQ10, kot aktivne snovi z majhnim tveganjem v skladu z Uredbo (ES) št. 1107/2009 Evropskega parlamenta in Sveta o dajanju fitofarmacevtskih sredstev v promet ter o spremembi Priloge k Izvedbeni uredbi Komisije (EU) št. 540/2011
Having regard to Regulation (EC) No 1107/2009 of the European Parliament and of the Council of 21 October 2009 concerning the placing of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC, and in particular Article 22(1) in conjunction with Article 20(1) thereof,
ob upoštevanju Uredbe (ES) št. 1107/2009 Evropskega parlamenta in Sveta z dne 21. oktobra 2009 o dajanju fitofarmacevtskih sredstev v promet in razveljavitvi direktiv Sveta 79/117/EGS in 91/414/EGS ter zlasti člena 22(1) v povezavi s členom 20(1) Uredbe,
Commission Directive 2005/2/EC included Ampelomyces quisqualis strain AQ10 as an active substance in Annex I to Council Directive 91/414/EEC.
Direktiva Komisije 2005/2/ES je vključila Ampelomyces quisqualis, sev AQ10, kot aktivno snov v Prilogo I k Direktivi Sveta 91/414/EGS.
The approval of the active substance Ampelomyces quisqualis strain AQ10, as set out in Part A of the Annex to Implementing Regulation (EU) No 540/2011, expires on 31 July 2018.
Odobritev aktivne snovi Ampelomyces quisqualis, sev AQ10, kot je določena v delu A Priloge k Izvedbeni uredbi (EU) št. 540/2011, preneha veljati 31. julija 2018.
An application for the renewal of the approval of Ampelomyces quisqualis strain AQ10 was submitted in accordance with Article 1 of Commission Implementing Regulation (EU) No 844/2012 within the time period provided for in that Article.
Zahtevek za obnovitev odobritve Ampelomyces quisqualis, sev AQ10, je bil predložen v skladu s členom 1 Izvedbene uredbe Komisije (EU) št. 844/2012 v roku, določenem v navedenem členu.
The rapporteur Member State prepared a renewal assessment report in consultation with the co-rapporteur Member State and submitted it to the European Food Safety Authority (‘the Authority’) and the Commission on the 25 November 2016.
Država članica poročevalka je pripravila poročilo o oceni obnovitve v posvetovanju z državo članico soporočevalko ter ga 25. novembra 2016 predložila Evropski agenciji za varnost hrane (v nadaljnjem besedilu: Agencija) in Komisiji.
On the 20 November 2017 the Authority communicated to the Commission its conclusion on whether Ampelomyces quisqualis strain AQ10 can be expected to meet the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009.
Komisiji je 20. novembra 2017 predložila svoj sklep o tem, ali se za Ampelomyces quisqualis, sev AQ10, lahko pričakuje, da bo izpolnjeval merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009.
The Commission presented the draft renewal report for Ampelomyces quisqualis strain AQ10 to the Standing Committee on Plants, Animals, Food and Feed on 23 March 2018.
Komisija je osnutek poročila o obnovitvi Ampelomyces quisqualis, sev AQ10, 23. marca 2018 predložila Stalnemu odboru za rastline, živali, hrano in krmo.
It has been established with respect to one or more representative uses of at least one plant protection product containing Ampelomyces quisqualis strain AQ10 that the approval criteria provided for in Article 4 of Regulation (EC) No 1107/2009 are satisfied.
V zvezi z eno ali več reprezentativnimi uporabami vsaj enega fitofarmacevtskega sredstva, ki vsebuje Ampelomyces quisqualis, sev AQ10, je bilo ugotovljeno, da so merila za odobritev iz člena 4 Uredbe (ES) št. 1107/2009 izpolnjena.
The risk assessment for the renewal of the approval of Ampelomyces quisqualis strain AQ10 is based on a limited number of representative uses, which however do not restrict the uses for which plant protection products containing Ampelomyces quisqualis strain AQ10 may be authorised.
Ocena tveganja za obnovitev odobritve Ampelomyces quisqualis, sev AQ10, temelji na omejenem številu reprezentativnih uporab, ki pa ne omejujejo uporab, za katere se za fitofarmacevtska sredstva, ki vsebujejo Ampelomyces quisqualis, sev AQ10, lahko registrirajo.
The Commission further considers that Ampelomyces quisqualis strain AQ10 is a low-risk active substance pursuant to Article 22 of Regulation (EC) No 1107/2009.
Komisija poleg tega meni, da je Ampelomyces quisqualis, sev AQ10, aktivna snov z majhnim tveganjem v skladu s členom 22 Uredbe (ES) št. 1107/2009.
Ampelomyces quisqualis strain AQ10 fulfils the conditions set in point 5 of Annex II to Regulation (EC) No 1107/2009.
Ampelomyces quisqualis, sev AQ10, izpolnjuje pogoje iz točke 5 Priloge II k Uredbi (ES) št. 1107/2009.
Ampelomyces quisqualis strain AQ10 is a strain of a micro-organism which, taking into account the intended uses, is expected to pose a low risk to humans, animals and the environment.
Ampelomyces quisqualis, sev AQ10, je sev mikroorganizma, za katerega se ob upoštevanju predvidenih uporab pričakuje, da bo predstavljal majhno tveganje za ljudi, živali in okolje.
Furthermore, Ampelomyces quisqualis strain AQ10 is a strain of a micro-organism (fungus) which is not pathogenic to humans, nor related to any known human, animal or plant pathogen, and for which no multiple resistance to antimicrobials used in human or veterinary medicine is known.
Poleg tega je Ampelomyces quisqualis, sev AQ10, sev mikroorganizma (plesni), ki ni niti patogen za ljudi niti povezan s kakršnim koli znanim patogenom za ljudi, živali ali rastline ter za katerega ni znana nobena večkratna odpornost proti antimikrobikom, ki se uporabljajo v humani ali veterinarski medicini.
It is therefore appropriate to renew the approval of Ampelomyces quisqualis strain AQ10 as a low-risk substance.
Zato je primerno obnoviti odobritev Ampelomyces quisqualis, sev AQ10, kot snovi z majhnim tveganjem.
Commission Implementing Regulation (EU) No 841/2017 extended the expiry date of the approval of Ampelomyces quisqualis strain AQ10 to 31 July 2018 in order to allow the renewal process to be completed before the expiry of the approval of that substance.
Z Izvedbeno uredbo Komisije (EU) 2017/841 je bilo podaljšano obdobje odobritve Ampelomyces quisqualis, sev AQ10, do 31. julija 2018, da bi se omogočil zaključek postopka obnovitve pred prenehanjem odobritve navedene snovi.
Taking into account that the approval of the active substance expires on 31 July 2018, this Regulation should apply from 1 August 2018.
Ob upoštevanju, da odobritev aktivne snovi preneha veljati 31. julija 2018, bi morala ta uredba začeti veljati 1. avgusta 2018.
The approval of the active substance Ampelomyces quisqualis strain AQ10, as set out in Annex I, is renewed subject to the conditions laid down in that Annex.
Odobritev aktivne snovi Ampelomyces quisqualis, sev AQ10, kot je določena v Prilogi I, se obnovi v skladu s pogoji iz navedene priloge.
Commission Directive 2005/2/EC of 19 January 2005 amending Council Directive 91/414/EEC to include Ampelomyces quisqualis and Gliocladium catenulatum as active substances.
Direktiva Komisije 2005/2/ES z dne 19. januarja 2005 o spremembi Direktive Sveta 91/414/EGS zaradi vključitve Ampelomyces quisqualis in Gliocladium catenulatum na seznam aktivnih snovi.
(OJ L 20, 22.1.2005, p. 15).
(UL L 20, 22.1.2005, str. 15).
EFSA Journal 2017;15(11):5078, 24 pp. doi:10.2903/j.efsa.2017.5078 Available online: www.efsa.europa.eu.
EFSA Journal 2017;15(11):5078, 24 str. doi:10.2903/j.efsa.2017.5078.
Commission Implementing Regulation (EU) 2017/841 of 17 May 2017 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, Ampelomyces quisqualis strain: aq 10, benalaxyl, bentazone, bifenazate, bromoxynil, carfentrazone ethyl, chlorpropham, cyazofamid, desmedipham, diquat, DPX KE 459 (flupyrsulfuron-methyl), etoxazole, famoxadone, fenamidone, flumioxazine, foramsulfuron, Gliocladium catenulatum strain: j1446, imazamox, imazosulfuron, isoxaflutole, laminarin, metalaxyl-m, methoxyfenozide, milbemectin, oxasulfuron, pendimethalin, phenmedipham, pymetrozine, s-metolachlor, and trifloxystrobin (OJ L 125, 18.5.2017, p. 12).
Na voljo na spletu: www.efsa.europa.eu.
ANNEX I
Izvedbena uredba Komisije (EU) 2017/841 z dne 17. maja 2017 o spremembi Izvedbene uredbe (EU) št. 540/2011 glede podaljšanja obdobij odobritve za aktivne snovi alfa-cipermetrin, Ampelomyces quisqualis sev: AQ 10, benalaksil, bentazon, bifenazat, bromoksinil, karfentrazon-etil, klorprofam, ciazofamid, desmedifam, dikvat, DPX KE 459 (flupirsulfuron-metil), etoksazol, famoksadon, fenamidon, flumioksazin, foramsulfuron, Gliocladium catenulatum sev: J1446, imazamoks, imazosulfuron, izoksaflutol, laminarin, metalaksil-M, metoksifenozid, milbemektin, oksasulfuron, pendimetalin, fenmedifam, pimetrozin, S-metolaklor in trifloksistrobin (UL L 125, 18.5.2017, str. 12).
Purity
Ime po IUPAC
Date of approval
Čistost
Expiration of approval
Uveljavitev
Specific provisions
Veljavnost registracije
Ampelomyces quisqualis strain AQ10
Posebne določbe
Not applicable
Ampelomyces quisqualis, sev AQ10
1 August 2018
Minimalna vsebina živih spor:
1 August 2033
1. avgust 2018
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Ampelomyces quisqualis strain AQ10, and in particular Appendices I and II thereof, shall be taken into account.
1. avgust 2033
In this overall assessment Member States shall pay particular attention to the protection of operators and workers, taking into account that microorganisms are per se considered as potential sensitizers and ensuring that adequate personal protective equipment is included as a condition of use.
Za izvajanje enotnih načel iz člena 29(6) Uredbe (ES) št. 1107/2009 se upoštevajo ugotovitve iz poročila o obnovitvi Ampelomyces quisqualis, sev AQ10, ter zlasti dodatka I in II k poročilu.
Strict maintenance of environmental conditions and quality control analysis during the manufacturing process shall be assured by the producer.
V tej celoviti oceni morajo biti države članice zlasti pozorne na zaščito izvajalcev in delavcev ob upoštevanju, da lahko mikroorganizmi sami po sebi povzročajo preobčutljivost, ter morajo zagotoviti, da je med pogoji uporabe navedena uporaba ustrezne osebne zaščitne opreme.
in Part A, the entry on Ampelomyces quisqualis strain AQ10 is deleted;
Priloga k Izvedbeni uredbi (EU) št. 540/2011 se spremeni:
in Part D, the following entry is added:
v delu A se vnos za Ampelomyces quisqualis, sev AQ10, črta;
For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the renewal report on Ampelomyces quisqualis strain AQ10, and in particular Appendices I and II thereof, shall be taken into account.
Številka
Conditions of use shall include risk mitigation measures, where appropriate.’
Za izvajanje enotnih načel iz člena 29(6) Uredbe (ES) št. 1107/2009 se upoštevajo ugotovitve iz poročila o obnovitvi Ampelomyces quisqualis, sev AQ10, ter zlasti dodatka I in II k poročilu.
Commission Implementing Regulation (EU) 2018/1076
Izvedbena uredba Komisije (EU) 2018/1076
amending Regulation (EU) No 37/2010 to classify the substance isoflurane as regards its maximum residue limit
o spremembi Uredbe (EU) št. 37/2010 za razvrstitev snovi izofluran glede najvišje mejne vrednosti ostanka
Having regard to Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and the Council, and in particular Article 14 in conjunction with Article 17 thereof,
ob upoštevanju Uredbe (ES) št. 470/2009 Evropskega parlamenta in Sveta z dne 6. maja 2009 o določitvi postopkov Skupnosti za določitev mejnih vrednosti ostankov farmakološko aktivnih snovi v živilih živalskega izvora in razveljavitvi Uredbe Sveta (EGS) št. 2377/90 in spremembi Direktive 2001/82/ES Evropskega parlamenta in Sveta ter Uredbe (ES) št. 726/2004 Evropskega parlamenta in Sveta ter zlasti člena 14 v povezavi s členom 17 Uredbe,
Isoflurane is already included in that table as an allowed substance for equidae, for anaesthetic use only.
Izofluran je že vključen v navedeno razpredelnico kot dovoljena snov za enoprste kopitarje samo za uporabo kot anestetik.
The existing entry has a ‘no MRL required’ classification.
Obstoječi vnos je razvrščen med tiste, ki nosijo oznako „MRL se ne zahteva“.
An application for the extension of the existing entry for isoflurane to porcine species has been submitted to the European Medicines Agency (‘EMA’).
Evropski agenciji za zdravila (v nadaljnjem besedilu: EMA) je bila predložena vloga za razširitev obstoječega vnosa za izofluran na prašiče.
EMA, based on the opinion of the Committee for Medicinal Products for Veterinary Use, has recommended the establishment of an MRL for isoflurane in porcine species.
EMA je na podlagi mnenja Odbora za zdravila za uporabo v veterinarski medicini priporočila določitev MRL za izofluran v prašičih.
EMA has considered that the extrapolation of the entry for isoflurane to other age groups and species cannot be reliably assessed at this time due to insufficient data.
EMA je menila, da ekstrapolacije vnosa za izofluran na druge starostne skupine in vrste trenutno ni mogoče zanesljivo oceniti zaradi nezadostnih podatkov.
It is appropriate to grant the stakeholders concerned a reasonable period of time to take measures that may be required to comply with the new MRL.
Primerno je, da se zadevnim zainteresiranim stranem zagotovi razumno časovno obdobje za sprejetje ukrepov, ki so morda potrebni za uskladitev z novo MRL.
It shall apply from 29 September 2018.
Uporablja se od 29. septembra 2018.
In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘isoflurane’ is replaced by the following:
V razpredelnici 1 Priloge k Uredbi (EU) št. 37/2010 se vnos za snov „izofluran“ nadomesti z naslednjim:
Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Druge določbe (v skladu s členom 14(7) Uredbe (ES) št. 470/2009)
‘Isoflurane
„izofluran
For use by inhalation
Za uporabo z vdihavanjem.
General anaesthetics’
splošni anestetik“
For use by inhalation in piglets up to 7 days of age
Za uporabo z vdihavanjem pri odstavljenih pujskih, ki so stari do sedem dni.
Commission Implementing Regulation (EU) 2018/1077
Izvedbena uredba Komisije (EU) 2018/1077
amending Implementing Regulation (EU) No 808/2014 laying down rules for the application of Regulation (EU) No 1305/2013 of the European Parliament and of the Council on support for rural development by the European Agricultural Fund for Rural Development (EAFRD)
o spremembi Izvedbene uredbe (EU) št. 808/2014 o določitvi pravil za uporabo Uredbe (EU) št. 1305/2013 Evropskega parlamenta in Sveta o podpori za razvoj podeželja iz Evropskega kmetijskega sklada za razvoj podeželja (EKSRP)
Having regard to Regulation (EU) No 1305/2013 of the European Parliament and of the Council of 17 December 2013 on support for rural development by the European Agricultural Fund for Rural Development (EAFRD) and repealing Council Regulation (EC) No 1698/2005, and in particular Article 8(3) thereof,
ob upoštevanju Uredbe (EU) št. 1305/2013 Evropskega parlamenta in Sveta z dne 17. decembra 2013 o podpori za razvoj podeželja iz Evropskega kmetijskega sklada za razvoj podeželja (EKSRP) in razveljavitvi Uredbe Sveta (ES) št. 1698/2005 ter zlasti člena 8(3) Uredbe,
Commission Implementing Regulation (EU) No 808/2014 has laid down rules for the application of Regulation (EU) No 1305/2013.
Izvedbena uredba Komisije (EU) št. 808/2014 določa pravila za uporabo Uredbe (EU) št. 1305/2013.
Regulation (EU) 2017/2393 of the European Parliament and of the Council has amended Regulation (EU) No 1305/2013 by simplifying the general rules governing the European Agricultural Fund for Rural Development (EAFRD).
Uredba (EU) 2017/2393 Evropskega parlamenta in Sveta spreminja Uredbo (EU) št. 1305/2013 s poenostavitvijo splošnih pravil, ki urejajo Evropski kmetijski sklad za razvoj podeželja (EKSRP).
Therefore, the rules for the implementation of Regulation (EU) No 1305/2013 should be amended accordingly.
Zato bi bilo treba pravila za izvajanje Uredbe (EU) št. 1305/2013 ustrezno spremeniti.
The obligation to select bodies to provide advice through a specific call for tenders procedure was abolished.
Obveznost za izbiro organov, ki bi zagotavljali svetovanje preko posebnega postopka za razpise za zbiranje ponudb, je bila ukinjena.
Therefore, implementing rules referring to the calls for tenders should be deleted.
Zato bi bilo treba črtati izvedbena pravila, ki se nanašajo na razpise za zbiranje ponudb.
Rules for joint setting up of young farmers have been introduced in Article 2(1)(n) of Regulation (EU) No 1305/2013 and a definition of the ‘date of setting up’ has been added in Article 2(1)(s) of that Regulation.
V člen 2(1)(n) Uredbe (EU) št. 1305/2013 so bila uvedena pravila za skupno vzpostavitev mladih kmetov, v člen 2(1)(s) navedene uredbe pa je bila dodana opredelitev pojma „datum vzpostavitve“.
Therefore, provisions referring to the young farmer set out in paragraph 8 of Part 1 of Annex I to Implementing Regulation (EU) No 808/2014 should be aligned.
Zato bi bilo treba uskladiti določbe, ki se nanašajo na mladega kmeta iz odstavka 8 v delu 1 Priloge I k Izvedbeni uredbi (EU) št. 808/2014.
Moreover, following the deletion of Article 57 of Commission Implementing Regulation (EU) No 809/2014 containing rules on Farm and business development, the rules for business plan laid down in Implementing Regulation (EU) No 808/2014 should also be simplified.
Poleg tega bi bilo treba zaradi črtanja člena 57 Izvedbene uredbe Komisije (EU) št. 809/2014, ki vsebuje pravila o razvoju kmetij in podjetij, pravila za poslovni načrt iz Izvedbene uredbe (EU) št. 808/2014 prav tako poenostaviti.
The rules on financial instruments have been simplified.
Pravila o finančnih instrumentih so bila poenostavljena.
Notably, a derogation from the applicability of selection criteria for operations supported through financial instruments has been introduced in Article 49(4) of Regulation (EU) No 1305/2013.
Zlasti je bilo v člen 49(4) Uredbe (EU) št. 1305/2013 uvedeno odstopanje od uporabe meril za izbor za operacije, ki prejemajo pomoč v okviru finančnih instrumentov.
Paragraph 8 of Part 1 of Annex I to Implementing Regulation (EU) No 808/2014 should be aligned with this derogation.
Odstavek 8 v delu 1 Priloge I k Izvedbeni uredbi (EU) št. 808/2014 bi bilo treba uskladiti s tem odstopanjem.
In order to avoid unnecessary administrative burden and in particular frequent modifications of the financing plans, it is necessary to clarify that the capping related to the overrun of the planned EAFRD contributions as presented in the financial plan of each programme is calculated at the level of the total amount of each measure.
Da bi se izognili nepotrebnemu upravnemu bremenu in zlasti pogostim spremembam finančnih načrtov, je treba pojasniti, da se omejitev v zvezi s prekoračitvijo načrtovanih prispevkov EKSRP, kot so predstavljeni v finančnem načrtu vsakega programa, izračuna na ravni skupnega zneska vsakega ukrepa.
Article 39a of Regulation (EU) No 1305/2013 provides for support to farmers through a sector specific income stabilisation tool and Article 37 of that Regulation allows for support to agricultural insurance schemes covering production losses exceeding 20 % of an annual average caused by adverse climatic events, animal or plant diseases, pest infestation, or an environmental incident.
Člen 39a Uredbe (EU) št. 1305/2013 določa podporo kmetom preko sektorskega instrumenta za stabilizacijo dohodka, člen 37 navedene uredbe pa omogoča podporo kmetijskim zavarovalnim shemam, ki pokrivajo proizvodne izgube, ki presegajo 20 % letnega povprečja in so nastale zaradi slabih vremenskih razmer, bolezni živali ali rastlin, napada škodljivcev ali okoljske nesreče.
In accordance with Article 8(1)(h) of Regulation (EU) No 1305/2013, the financing plan should indicate the planned EAFRD support and the contribution rate.
V skladu s členom 8(1)(h) Uredbe (EU) št. 1305/2013 bi moral finančni načrt navesti načrtovano podporo EKSRP in stopnjo prispevka.
in Article 8, paragraph 1 is deleted;
v členu 8 se črta odstavek 1;
Part 1 of Annex I is amended as follows:
del 1 Priloge I se spremeni: